A research letter in JAMA Internal Medicine describes consumer reactions to drug pricing disclosure.
Read More
A report from PriceWaterhouse Cooper evaluates the year that was in health care M & A.
Read More
Population health, disease management, digital health, mobile app, (and any other buzzword) firm Livongo is acquiring myStrength, a behavioral health firm with the same buzzwords, for an undisclosed, but hopefully weak, amount.
https://www.fiercebiotech.com/medtech/livongo-dives-into-behavioral-health-mystrength-buy?mkt_tok=eyJpIjoiTVRrMk9UUTVOekEzTkdJNSIsInQiOiJialJHQTF4Wng3Q2JGMXkyTWViVDdFajl6REFUcmNvV1pVemM0RHZ3MkhZTnJRcERiZEl4OG5SdWdmZTlPdTNoOFUyWkVaZXpab1oxVmRPdFB2SVNPZEFPbTF5aHBwQUZ1TEJNcHdZU0loRjR0M0s3U0E2S1lUUXRQU1wvcnJmeHgifQ%3D%3D&mrkid=635530&utm_medium=nl&utm_source=internalEBSCO Health, part of a large multi-industry information firm, is buying Health Decision, a clinical support vendor.
https://medcitynews.com/2019/01/ebsco-health-healthdecision/?utm_campaign=MCN%20Daily%20Top%20Stories&utm_source=hs_email&utm_medium=email&utm_content=69348244&_hsenc=p2ANqtz-9onAPVvakGAfiov0KapC2rYbr2mYl0kynNC-3ELtJysfhjszSWlZjr-RhsjOnKmRumvakyx9xxOl5kSdbm6L-53y4but3442JUoFsTxYYkgXAqJyc&_hsmi=69348244&rf=1A report from IQVIA covers expected spending and trends in global drug use over the next few years.
Read More
Rising drug prices are contributing to hospitals' increased costs of delivering care.
Read More
More bad news for the hospital readmission reduction program, as a new study in Health Affairs concludes that it had far less effect than previously estimated.
Read More
Bright Health has raised a fresh $200 million in capital to support its individual health plan business, which has expanded to a number of markets. No word on whether it is actually making money yet.
https://www.prnewswire.com/news-releases/bright-health-announces-200-million-series-c-funding-round-as-unique-care-partner-health-plan-model-ushers-in-the-next-generation-of-healthcare-300757092.htmlThe annual ECRI Institute list of health safety hazards is out.
Read More
A McKinsey post addresses issues around patient adherence to treatment regimens.
Read More